Chengjin Ye
Texas Biomedical Research Institute(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Viral gastroenteritis research and epidemiology, Virus-based gene therapy research, Animal Virus Infections Studies, COVID-19 Clinical Research Studies
Most-Cited Works
- → SARS-CoV-2 spike E484K mutation reduces antibody neutralisation(2021)434 cited
- → Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice(2020)421 cited
- → SARS-CoV-2 replication in airway epithelia requires motile cilia and microvillar reprogramming(2022)201 cited
- → Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors(2023)166 cited
- → Rescue of SARS-CoV-2 from a Single Bacterial Artificial Chromosome(2020)154 cited
- → The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera(2021)146 cited
- → Binding of the pathogen receptor HSP90AA1 to avibirnavirus VP2 induces autophagy by inactivating the AKT-MTOR pathway(2015)144 cited
- → Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice(2021)141 cited
- → SARS-CoV-2 3CL pro mutations selected in a VSV-based system confer resistance to nirmatrelvir, ensitrelvir, and GC376(2022)132 cited
- → Oral prodrug of remdesivir parent GS-441524 is efficacious against SARS-CoV-2 in ferrets(2021)122 cited